Germany is the biggest pharma market in Europe. A big hurdle in market access of innovative drugs in Germany is the benefit assessment, the so-called "AMNOG procedure". In this webinar, we outline some of the most relevant and critical aspects of the AMNOG procedure – to show you what you should consider for successful market access in Germany.